Go to the Table of Contents

Search tables for keyword
Please note: A selected table may take a few minutes to load.

210609
Table 11.1C – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; Standard Errors of Numbers in Thousands, 2002-2020
Setting Where Mental Health Service
Was Received
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
SPECIALTY MENTAL HEALTH SERVICE1 70 71 78 75 74 77 72 74 73 75 70 80 84 80 81 89 92 93 187
Outpatient 67 68 75 73 72 72 70 70 68 73 67 75 80 77 78 86 87 92 186
Private Therapist, Psychologist,
   Psychiatrist, Social Worker, or
   Counselor
63 61 64 66 65 67 68 65 63 67 65 68 76 74 74 81 83 85 173
Mental Health Clinic or Center 35 31 38 34 33 30 33 32 32 30 31 40 39 41 43 47 49 54 110
Partial Day Hospital or Day Treatment
   Program
27 25 28 29 31 28 26 24 26 26 25 31 33 31 34 34 34 34 42
In-Home Therapist, Counselor, or Family
   Preservation Worker
33 32 40 36 37 37 36 35 34 39 38 40 41 42 39 41 46 55 98
Inpatient or Residential1 31 33 35 35 35 33 31 31 31 31 31 35 38 38 40 40 40 38 68
Hospital 28 31 32 30 33 31 28 28 28 28 29 32 36 36 38 37 37 36 59
Residential Treatment Center 20 23 24 22 20 17 19 20 19 22 20 21 23 23 26 26 25 26 49
NONSPECIALTY MENTAL HEALTH
   SERVICE2
nc nc nc nc nc nc nc 79 75 75 74 80 85 86 85 87 89 96 157
Education2,3 nc nc nc nc nc nc nc 73 70 68 70 78 81 82 80 83 85 91 149
School Social Worker, School Psychologist,
   or School Counselor
nc nc nc nc nc nc nc 63 64 61 63 65 72 72 68 70 76 79 132
Special School or Program within a Regular
   School for Students with Emotional or
   Behavioral Problems
nc nc nc nc nc nc nc 43 42 46 47 48 51 53 55 57 53 59 96
General Medicine                                      
Pediatrician or Other Family Doctor 33 37 36 42 35 35 36 34 33 35 32 36 38 38 38 43 42 44 70
Juvenile Justice                                      
Juvenile Detention Center, Prison, or Jail -- -- -- -- -- -- -- 14 12 14 12 10 12 10 11 10 11 10 10
Child Welfare                                      
Foster Care or Therapeutic Foster Care 15 19 18 17 17 13 14 13 14 18 13 13 14 13 16 14 15 17 21
SPECIALTY MENTAL HEALTH SERVICES
AND EDUCATION, GENERAL MEDICINE
OR CHILD WELFARE SERVICES1,2,3
nc nc nc nc nc nc nc 48 47 49 49 52 57 52 56 62 62 67 109
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded. Questions on virtual services were added in Quarter 4 of 2020. Estimates in this table do not include data from these questions. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these 2002 to 2012 estimates may differ from estimates published prior to the 2013 NSDUH.
2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to the 2009 NSDUH.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2019, and Quarters 1 and 4, 2020.
210609
Table 11.1D – Settings Where Mental Health Services Were Received in Past Year: Among People Aged 12 to 17; Standard Errors of Percentages, 2002-2020
Setting Where Mental Health Service
Was Received
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
SPECIALTY MENTAL HEALTH SERVICE1 0.28 0.28 0.31 0.30 0.29 0.31 0.29 0.30 0.30 0.31 0.28 0.32 0.34 0.32 0.33 0.36 0.38 0.38 0.76
Outpatient 0.27 0.27 0.30 0.29 0.29 0.29 0.29 0.29 0.28 0.30 0.27 0.31 0.33 0.31 0.32 0.35 0.36 0.38 0.76
Private Therapist, Psychologist,
   Psychiatrist, Social Worker, or
   Counselor
0.25 0.25 0.26 0.26 0.26 0.27 0.27 0.27 0.26 0.27 0.26 0.28 0.31 0.30 0.30 0.33 0.34 0.35 0.70
Mental Health Clinic or Center 0.14 0.13 0.15 0.14 0.13 0.12 0.13 0.13 0.13 0.12 0.13 0.16 0.16 0.17 0.18 0.19 0.20 0.22 0.45
Partial Day Hospital or Day Treatment
   Program
0.11 0.10 0.11 0.11 0.12 0.11 0.10 0.10 0.11 0.10 0.10 0.13 0.13 0.12 0.14 0.14 0.14 0.14 0.17
In-Home Therapist, Counselor, or Family
   Preservation Worker
0.13 0.13 0.16 0.14 0.15 0.15 0.15 0.14 0.14 0.16 0.15 0.16 0.17 0.17 0.16 0.17 0.19 0.22 0.40
Inpatient or Residential1 0.12 0.13 0.14 0.14 0.14 0.13 0.13 0.13 0.13 0.13 0.13 0.14 0.15 0.15 0.16 0.16 0.16 0.15 0.28
Hospital 0.11 0.12 0.13 0.12 0.13 0.12 0.11 0.11 0.12 0.11 0.12 0.13 0.15 0.15 0.16 0.15 0.15 0.15 0.24
Residential Treatment Center 0.08 0.09 0.09 0.09 0.08 0.07 0.08 0.08 0.08 0.09 0.08 0.08 0.09 0.09 0.11 0.11 0.10 0.10 0.20
NONSPECIALTY MENTAL HEALTH
   SERVICE2
nc nc nc nc nc nc nc 0.33 0.32 0.31 0.30 0.33 0.35 0.35 0.35 0.36 0.37 0.40 0.64
Education2,3 nc nc nc nc nc nc nc 0.30 0.29 0.28 0.29 0.32 0.33 0.34 0.33 0.34 0.35 0.37 0.61
School Social Worker, School Psychologist,
   or School Counselor
nc nc nc nc nc nc nc 0.26 0.27 0.25 0.26 0.27 0.29 0.30 0.28 0.29 0.31 0.33 0.54
Special School or Program within a Regular
   School for Students with Emotional or
   Behavioral Problems
nc nc nc nc nc nc nc 0.18 0.18 0.19 0.19 0.20 0.21 0.22 0.23 0.23 0.22 0.24 0.39
General Medicine                                      
Pediatrician or Other Family Doctor 0.13 0.15 0.15 0.17 0.14 0.14 0.14 0.14 0.14 0.14 0.13 0.15 0.15 0.16 0.15 0.17 0.17 0.18 0.29
Juvenile Justice                                      
Juvenile Detention Center, Prison, or Jail -- -- -- -- -- -- -- 0.06 0.05 0.06 0.05 0.04 0.05 0.04 0.05 0.04 0.04 0.04 0.04
Child Welfare                                      
Foster Care or Therapeutic Foster Care 0.06 0.08 0.07 0.07 0.07 0.05 0.06 0.05 0.06 0.07 0.05 0.05 0.06 0.05 0.07 0.06 0.06 0.07 0.09
SPECIALTY MENTAL HEALTH SERVICES
AND EDUCATION, GENERAL MEDICINE
OR CHILD WELFARE SERVICES1,2,3
nc nc nc nc nc nc nc 0.20 0.20 0.20 0.20 0.21 0.23 0.21 0.23 0.25 0.25 0.27 0.45
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Mental health services for people aged 12 to 17 includes treatment/counseling for emotional or behavioral problems not caused by drug or alcohol use. Respondents with unknown mental health service information were excluded. Questions on virtual services were added in Quarter 4 of 2020. Estimates in this table do not include data from these questions. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Respondents could indicate multiple service settings; thus, the response categories are not mutually exclusive.
1 Because of revisions in 2013 to Specialty Mental Health Service estimates, these 2002 to 2012 estimates may differ from estimates published prior to the 2013 NSDUH.
2 Because of revisions in 2009 to the questions on the Source of Youth Mental Health Education Services, these estimates are not comparable with the education services estimates published prior to the 2009 NSDUH.
3 Respondents who did not report their school enrollment status, who reported not being enrolled in school in the past 12 months, or who reported being home-schooled were not asked about receipt of mental health services from this setting; however, respondents who reported not being enrolled in school in the past 12 months were classified as not having received mental health services from this setting.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2002-2019, and Quarters 1 and 4, 2020.
210609
Table 11.2C – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2004-2020
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 62 63 60 63 60 59 57 58 63 72 77 80 77 85 88 90 199
AGE GROUP                                  
12-13 29 27 27 25 27 26 25 24 29 32 37 38 34 35 39 40 127
14-15 37 40 34 36 37 39 34 38 40 49 48 53 47 52 56 61 124
16-17 48 42 45 44 44 41 41 45 42 46 52 54 59 63 70 63 130
GENDER                                  
Male 32 32 32 33 30 32 30 32 32 40 39 41 42 44 47 47 105
Female 51 52 50 51 50 46 45 49 51 57 63 69 62 69 70 75 154
HISPANIC ORIGIN AND RACE                                  
Not Hispanic or Latino 56 56 51 57 54 53 51 50 53 61 66 68 67 71 73 73 172
White 53 53 45 53 49 48 49 46 48 56 62 66 63 68 68 72 166
Black or African American 26 27 22 26 25 27 22 22 23 25 26 25 24 28 28 29 60
AIAN 3 3 3 2 5 3 2 5 3 2 3 * 5 7 7 5 *
NHOPI * * * * * * 1 * * * * * * * * * *
Asian 17 12 21 15 19 14 12 17 12 22 20 18 22 21 27 30 58
Two or More Races 10 7 12 7 10 6 9 12 12 13 12 15 14 15 16 19 41
Hispanic or Latino 28 29 29 26 27 26 27 32 33 38 38 41 40 44 46 52 102
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.2D – Major Depressive Episode in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Percentages, 2004-2020
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 0.25 0.25 0.24 0.25 0.25 0.24 0.24 0.24 0.26 0.30 0.32 0.33 0.32 0.35 0.36 0.37 0.82
AGE GROUP                                  
12-13 0.33 0.33 0.34 0.32 0.35 0.34 0.32 0.30 0.36 0.40 0.46 0.49 0.44 0.45 0.50 0.49 1.42
14-15 0.42 0.44 0.38 0.41 0.42 0.44 0.42 0.44 0.45 0.52 0.55 0.57 0.52 0.59 0.61 0.68 1.35
16-17 0.54 0.47 0.48 0.49 0.48 0.45 0.46 0.48 0.48 0.54 0.56 0.59 0.63 0.67 0.71 0.69 1.55
GENDER                                  
Male 0.25 0.25 0.25 0.26 0.24 0.26 0.25 0.26 0.25 0.33 0.31 0.33 0.34 0.36 0.38 0.38 0.85
Female 0.42 0.42 0.41 0.43 0.42 0.39 0.39 0.41 0.43 0.48 0.53 0.58 0.52 0.58 0.59 0.63 1.30
HISPANIC ORIGIN AND RACE                                  
Not Hispanic or Latino 0.27 0.27 0.25 0.28 0.28 0.27 0.27 0.26 0.28 0.32 0.35 0.36 0.36 0.39 0.40 0.41 0.95
White 0.31 0.32 0.27 0.33 0.31 0.31 0.33 0.31 0.33 0.37 0.43 0.46 0.44 0.47 0.48 0.50 1.18
Black or African American 0.63 0.64 0.52 0.63 0.62 0.71 0.59 0.59 0.60 0.68 0.71 0.70 0.69 0.75 0.79 0.85 1.81
AIAN 2.03 1.44 2.44 1.60 2.89 2.03 1.77 3.68 2.15 1.33 1.82 * 2.98 4.35 4.09 3.19 *
NHOPI * * * * * * 1.07 * * * * * * * * * *
Asian 1.64 1.17 1.98 1.42 1.80 1.39 1.11 1.33 0.98 1.63 1.52 1.43 1.63 1.52 1.79 2.02 2.80
Two or More Races 2.15 1.62 2.54 1.59 1.84 1.24 1.69 1.60 1.59 1.71 1.53 1.67 1.68 1.77 1.85 1.82 5.11
Hispanic or Latino 0.67 0.68 0.65 0.58 0.58 0.56 0.56 0.61 0.61 0.70 0.70 0.72 0.71 0.76 0.79 0.87 1.67
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.3C – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2006-2020
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 50 49 54 49 48 47 53 62 66 68 65 74 71 77 160
AGE GROUP                              
12-13 18 18 22 21 21 19 25 26 30 29 27 28 29 34 102
14-15 31 30 30 32 28 30 33 43 41 43 40 45 47 53 99
16-17 38 34 39 36 33 36 35 39 44 45 48 53 59 54 102
GENDER                              
Male 24 26 24 25 26 26 25 33 31 34 35 38 37 42 89
Female 44 41 45 40 39 37 45 51 56 59 53 62 60 65 133
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 43 45 48 44 42 41 44 52 55 58 58 62 63 65 130
White 37 41 44 39 41 35 40 47 52 55 53 56 56 60 120
Black or African American 17 20 21 22 17 20 16 20 21 20 19 24 22 25 48
AIAN 3 2 3 2 2 5 2 2 2 * 3 2 * 5 *
NHOPI * * * * * * * * * * * * * * *
Asian 19 10 16 11 10 14 9 20 16 13 19 18 21 26 47
Two or More Races 7 6 9 6 8 9 12 9 9 13 13 11 14 16 26
Hispanic or Latino 25 21 23 22 22 24 29 33 32 34 32 38 37 44 92
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.3D – Major Depressive Episode with Severe Impairment in Past Year: Among People Aged 12 to 17; by Demographic Characteristics, Standard Errors of Percentages, 2006-2020
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 0.20 0.20 0.22 0.20 0.20 0.19 0.22 0.26 0.27 0.28 0.27 0.31 0.29 0.32 0.66
AGE GROUP                              
12-13 0.22 0.23 0.28 0.28 0.27 0.24 0.31 0.33 0.38 0.38 0.36 0.36 0.36 0.43 1.16
14-15 0.35 0.35 0.35 0.36 0.34 0.36 0.38 0.47 0.48 0.49 0.46 0.51 0.53 0.60 1.09
16-17 0.42 0.39 0.43 0.40 0.38 0.39 0.40 0.46 0.49 0.52 0.53 0.59 0.61 0.62 1.26
GENDER                              
Male 0.18 0.20 0.20 0.21 0.21 0.21 0.20 0.26 0.25 0.28 0.28 0.30 0.30 0.34 0.72
Female 0.36 0.34 0.38 0.34 0.33 0.31 0.38 0.42 0.47 0.50 0.45 0.52 0.51 0.55 1.13
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 0.21 0.22 0.24 0.22 0.22 0.21 0.23 0.27 0.29 0.31 0.31 0.34 0.34 0.36 0.71
White 0.23 0.26 0.28 0.26 0.28 0.24 0.28 0.32 0.37 0.41 0.39 0.40 0.41 0.44 0.88
Black or African American 0.42 0.50 0.53 0.59 0.47 0.55 0.46 0.56 0.57 0.58 0.57 0.67 0.64 0.73 1.44
AIAN 1.91 1.07 2.27 1.66 1.58 3.56 1.31 1.24 1.49 * 2.19 1.17 * 3.12 *
NHOPI * * * * * * * * * * * * * * *
Asian 1.81 1.04 1.60 1.14 0.98 1.10 0.80 1.46 1.25 1.04 1.42 1.36 1.40 1.85 2.26
Two or More Races 1.67 1.50 1.76 1.12 1.45 1.23 1.56 1.22 1.25 1.56 1.57 1.32 1.73 1.67 3.49
Hispanic or Latino 0.57 0.47 0.49 0.48 0.47 0.46 0.54 0.61 0.59 0.61 0.57 0.66 0.64 0.74 1.51
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.4C – Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2004-2020
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 41 39 41 41 37 35 37 37 38 44 51 53 52 55 60 64 138
AGE GROUP                                  
12-13 17 14 16 17 14 12 14 13 15 20 21 19 20 22 24 24 *
14-15 22 26 21 22 22 19 22 21 23 27 28 35 30 32 36 40 73
16-17 31 25 30 27 27 26 25 28 26 28 35 35 37 40 41 42 69
GENDER                                  
Male 20 18 19 22 17 17 17 20 16 21 24 24 25 24 29 29 73
Female 35 34 36 34 33 30 32 32 33 39 44 48 46 51 53 57 105
HISPANIC ORIGIN AND RACE                                  
Not Hispanic or Latino 38 36 35 38 33 31 32 34 33 36 46 45 46 49 49 55 124
White 33 30 29 33 31 27 30 28 28 33 41 39 41 44 44 50 118
Black or African American 13 19 10 17 12 13 9 13 14 12 17 17 14 16 15 18 *
AIAN * * * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * 10 * 9 9 13 *
Hispanic or Latino 17 17 21 13 16 16 17 15 18 25 23 26 25 25 33 33 61
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.4D – Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; by Demographic Characteristics, Standard Errors of Percentages, 2004-2020
Demographic Characteristic 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 1.38 1.42 1.60 1.52 1.48 1.52 1.51 1.47 1.34 1.35 1.42 1.40 1.30 1.29 1.36 1.34 2.45
AGE GROUP                                  
12-13 3.18 2.89 3.39 3.73 3.27 3.31 3.68 3.51 2.96 3.45 3.22 2.91 3.15 3.23 3.00 2.50 *
14-15 2.25 2.46 2.49 2.51 2.55 2.27 2.52 2.45 2.19 2.15 2.27 2.27 2.20 2.15 2.26 2.27 3.92
16-17 2.14 2.04 2.44 2.10 2.19 2.36 2.32 2.23 2.02 2.00 2.28 2.11 1.83 1.96 2.00 1.99 3.32
GENDER                                  
Male 2.56 2.61 2.85 2.83 2.74 2.55 2.65 2.80 2.35 2.82 2.74 2.60 2.62 2.44 2.55 2.21 4.49
Female 1.67 1.61 1.88 1.83 1.74 1.79 1.82 1.74 1.61 1.55 1.66 1.62 1.48 1.53 1.58 1.62 2.73
HISPANIC ORIGIN AND RACE                                  
Not Hispanic or Latino 1.48 1.59 1.69 1.64 1.58 1.60 1.69 1.65 1.54 1.47 1.59 1.58 1.48 1.47 1.46 1.45 2.78
White 1.62 1.74 1.81 1.84 1.89 1.81 1.90 1.84 1.73 1.75 1.89 1.80 1.70 1.70 1.73 1.64 3.36
Black or African American 3.60 4.67 3.60 4.36 3.57 4.01 3.37 4.30 4.06 3.48 4.19 4.50 3.96 3.99 3.58 3.89 *
AIAN * * * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * 5.78 * 5.05 5.23 4.80 *
Hispanic or Latino 3.63 3.61 4.38 3.66 4.10 3.68 3.69 3.16 2.72 3.21 3.09 2.90 2.76 2.66 3.02 2.67 4.83
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.5C – Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; by Demographic Characteristics, Standard Errors of Numbers in Thousands, 2006-2020
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 37 35 33 32 31 33 34 41 43 46 45 50 53 58 112
AGE GROUP                              
12-13 12 13 13 11 10 12 13 19 17 17 17 20 19 21 *
14-15 20 20 19 16 19 20 20 25 24 30 27 28 31 37 65
16-17 28 23 24 25 22 23 22 26 31 31 33 37 36 38 59
GENDER                              
Male 15 18 14 15 15 17 14 19 19 22 21 20 26 26 64
Female 34 29 30 28 27 27 30 36 38 41 40 47 46 52 93
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 33 32 30 27 28 30 29 34 39 39 41 45 43 50 97
White 27 29 29 23 25 25 26 30 34 34 37 40 38 45 93
Black or African American 9 12 11 12 8 13 10 11 15 14 10 15 13 17 *
AIAN * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * * * 11 *
Hispanic or Latino 19 11 12 15 15 15 17 23 20 22 21 22 29 29 56
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.5D – Receipt of Treatment for Depression in Past Year: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; by Demographic Characteristics, Standard Errors of Percentages, 2006-2020
Demographic Characteristic 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
TOTAL 1.95 1.90 1.73 1.83 1.80 1.79 1.66 1.61 1.67 1.63 1.58 1.57 1.65 1.63 2.69
AGE GROUP                              
12-13 4.23 4.51 4.25 4.05 3.93 4.16 3.80 4.27 3.89 3.64 3.83 4.08 3.83 3.08 *
14-15 2.97 3.09 3.03 2.69 3.10 3.05 2.66 2.58 2.72 2.56 2.63 2.58 2.65 2.73 4.46
16-17 2.95 2.66 2.61 2.87 2.65 2.64 2.40 2.40 2.62 2.48 2.20 2.36 2.32 2.29 4.02
GENDER                              
Male 3.57 3.53 3.25 3.21 3.22 3.37 3.24 3.60 3.43 3.27 3.17 3.01 3.13 2.82 6.03
Female 2.24 2.25 2.06 2.12 2.18 2.07 1.96 1.83 1.90 1.87 1.78 1.78 1.89 1.89 3.00
HISPANIC ORIGIN AND RACE                              
Not Hispanic or Latino 2.07 2.06 1.92 1.90 1.99 1.97 1.86 1.76 1.90 1.84 1.79 1.76 1.73 1.76 2.95
White 2.16 2.33 2.22 2.12 2.18 2.23 2.12 2.07 2.19 2.05 2.03 2.07 2.08 1.88 3.60
Black or African American 4.80 4.98 4.31 5.08 4.62 5.03 4.76 4.40 5.04 5.20 4.49 4.76 4.64 4.93 *
AIAN * * * * * * * * * * * * * * *
NHOPI * * * * * * * * * * * * * * *
Asian * * * * * * * * * * * * * * *
Two or More Races * * * * * * * * * * * * * 5.79 *
Hispanic or Latino 5.64 4.22 4.37 4.65 4.59 4.36 3.42 3.89 3.76 3.57 3.60 3.22 3.77 3.51 5.82
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.6C – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; Standard Errors of Numbers in Thousands, 2004-2020
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                                  
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 46 47 46 54 55 113
Marijuana 35 32 32 31 32 30 29 32 31 36 39 39 40 39 46 50 99
Cocaine 11 12 11 11 12 8 9 9 10 7 11 9 8 8 10 10 17
Crack 6 5 6 7 5 4 4 5 3 2 5 * 3 2 0 6 *
Heroin 4 4 4 4 5 4 4 4 4 4 6 3 2 3 3 * *
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 18 16 18 16 20 37
LSD 9 9 5 5 8 8 6 7 8 7 12 13 9 13 11 18 27
PCP 8 5 4 3 5 4 3 5 3 3 5 2 3 5 4 6 *
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 10 12 10 10 16 14
Inhalants nc nc nc nc nc nc nc nc nc nc nc 22 19 17 20 24 56
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 7 3 5 4 6 *
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 29 30 30 31 32 39
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 23 26 21 24 22 20
Stimulants nc nc nc nc nc nc nc nc nc nc nc 21 19 21 17 27 31
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 15 18 20 20 24 30
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 14 19 20 19 23 29
Sedatives nc nc nc nc nc nc nc nc nc nc nc 7 8 6 10 14 7
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 13 18 20 19 23 26
Opioids nc nc nc nc nc nc nc nc nc nc nc 23 26 21 24 22 20
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc nc nc 21 20 22 20 28 35
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 37 35 36 38 39 72
PAST MONTH USE                                  
Alcohol 37 30 33 35 33 30 29 32 30 30 36 36 33 35 39 41 86
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 27 25 26 29 30 42
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 12 11 9 6 11 25
Cigarette Use 30 28 26 27 26 24 22 22 21 22 24 24 23 23 22 19 42
Daily Cigarette Use 17 14 14 14 11 11 9 11 9 7 11 12 6 7 7 4 5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.6D – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode in Past Year; Standard Errors of Percentages, 2004-2020
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                                  
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 1.28 1.25 1.19 1.21 1.16 2.27
Marijuana 1.29 1.25 1.38 1.33 1.37 1.34 1.35 1.37 1.18 1.22 1.24 1.16 1.14 1.09 1.09 1.10 2.11
Cocaine 0.47 0.53 0.53 0.54 0.57 0.39 0.45 0.45 0.44 0.26 0.40 0.29 0.27 0.24 0.30 0.27 0.42
Crack 0.26 0.22 0.30 0.32 0.26 0.19 0.19 0.23 0.15 0.08 0.18 * 0.09 0.05 0.01 0.17 *
Heroin 0.17 0.17 0.22 0.19 0.26 0.19 0.20 0.19 0.19 0.14 0.21 0.09 0.05 0.09 0.07 * *
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 0.58 0.52 0.55 0.47 0.50 0.87
LSD 0.41 0.39 0.28 0.22 0.38 0.41 0.29 0.33 0.35 0.26 0.43 0.42 0.30 0.41 0.32 0.46 0.64
PCP 0.34 0.21 0.20 0.16 0.27 0.20 0.18 0.24 0.12 0.13 0.19 0.06 0.08 0.17 0.11 0.15 *
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 0.32 0.37 0.31 0.29 0.41 0.33
Inhalants nc nc nc nc nc nc nc nc nc nc nc 0.70 0.59 0.53 0.56 0.62 1.29
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 0.22 0.08 0.15 0.11 0.15 *
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 0.91 0.91 0.88 0.85 0.79 0.92
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 0.75 0.80 0.64 0.67 0.57 0.49
Stimulants nc nc nc nc nc nc nc nc nc nc nc 0.67 0.59 0.64 0.49 0.67 0.73
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 0.48 0.59 0.61 0.57 0.61 0.70
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 0.45 0.59 0.60 0.54 0.59 0.68
Sedatives nc nc nc nc nc nc nc nc nc nc nc 0.24 0.27 0.17 0.29 0.37 0.16
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 0.44 0.57 0.60 0.53 0.59 0.60
Opioids nc nc nc nc nc nc nc nc nc nc nc 0.75 0.80 0.64 0.67 0.57 0.49
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc nc nc 0.69 0.64 0.65 0.55 0.69 0.80
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 1.12 1.01 1.01 1.00 0.91 1.59
PAST MONTH USE                                  
Alcohol 1.33 1.21 1.36 1.41 1.43 1.32 1.38 1.34 1.22 1.04 1.17 1.09 0.98 0.99 1.00 0.94 1.87
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 0.84 0.78 0.78 0.77 0.73 0.96
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 0.40 0.35 0.27 0.17 0.29 0.59
Cigarette Use 1.16 1.15 1.21 1.18 1.15 1.15 1.08 1.01 0.89 0.84 0.82 0.73 0.70 0.67 0.61 0.50 1.00
Daily Cigarette Use 0.75 0.61 0.68 0.66 0.53 0.54 0.45 0.53 0.41 0.27 0.40 0.40 0.20 0.23 0.21 0.12 0.11
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.7C – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; Standard Errors of Numbers in Thousands, 2006-2020
Substance 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                              
Illicit Drugs nc nc nc nc nc nc nc nc nc 42 40 40 47 48 78
Marijuana 27 25 29 27 23 26 27 30 35 36 35 33 41 43 68
Cocaine 8 10 11 7 7 8 9 5 9 9 8 7 8 10 14
Crack 4 7 2 3 3 5 3 2 3 * 3 2 0 6 *
Heroin 4 4 5 3 4 3 4 4 6 2 2 2 3 * *
Hallucinogens nc nc nc nc nc nc nc nc nc 18 15 17 15 19 35
LSD 4 4 7 6 5 6 8 5 12 13 8 12 10 17 24
PCP 4 3 5 2 2 4 3 3 5 2 3 5 4 6 *
Ecstasy nc nc nc nc nc nc nc nc nc 10 10 10 10 16 6
Inhalants nc nc nc nc nc nc nc nc nc 19 16 16 18 21 40
Methamphetamine nc nc nc nc nc nc nc nc nc 6 2 5 4 6 *
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc 27 27 27 27 31 37
Pain Relievers nc nc nc nc nc nc nc nc nc 21 23 18 20 21 17
Stimulants nc nc nc nc nc nc nc nc nc 20 18 20 16 25 30
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc 14 17 18 19 22 29
Tranquilizers nc nc nc nc nc nc nc nc nc 13 17 18 18 21 28
Sedatives nc nc nc nc nc nc nc nc nc 7 8 5 9 14 7
Benzodiazepines nc nc nc nc nc nc nc nc nc 13 17 18 18 21 25
Opioids nc nc nc nc nc nc nc nc nc 21 22 18 20 21 17
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc 21 19 20 17 26 32
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc 34 31 32 32 36 58
PAST MONTH USE                              
Alcohol 28 29 29 26 24 26 26 26 31 30 28 31 35 37 64
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc 24 21 24 26 27 37
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc 12 10 8 5 10 24
Cigarette Use 23 22 23 22 18 18 18 20 21 23 20 20 20 17 26
Daily Cigarette Use 12 11 10 9 7 9 8 6 11 12 5 7 6 4 5
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.7D – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with Major Depressive Episode with Severe Impairment in Past Year; Standard Errors of Percentages, 2006-2020
Substance 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                              
Illicit Drugs nc nc nc nc nc nc nc nc nc 1.55 1.43 1.49 1.51 1.40 2.37
Marijuana 1.71 1.55 1.62 1.63 1.56 1.57 1.46 1.43 1.49 1.42 1.34 1.32 1.39 1.34 2.21
Cocaine 0.59 0.71 0.72 0.48 0.54 0.55 0.58 0.27 0.47 0.42 0.35 0.29 0.32 0.38 0.48
Crack 0.31 0.47 0.17 0.20 0.24 0.33 0.22 0.11 0.16 * 0.12 0.07 0.01 0.24 *
Heroin 0.27 0.28 0.36 0.20 0.27 0.25 0.27 0.19 0.29 0.09 0.08 0.10 0.11 * *
Hallucinogens nc nc nc nc nc nc nc nc nc 0.81 0.65 0.74 0.61 0.69 1.18
LSD 0.30 0.31 0.47 0.43 0.39 0.40 0.51 0.26 0.58 0.59 0.37 0.53 0.41 0.62 0.83
PCP 0.28 0.20 0.36 0.16 0.17 0.25 0.17 0.17 0.26 0.09 0.12 0.24 0.16 0.21 *
Ecstasy nc nc nc nc nc nc nc nc nc 0.45 0.45 0.42 0.42 0.57 0.19
Inhalants nc nc nc nc nc nc nc nc nc 0.89 0.72 0.67 0.71 0.77 1.31
Methamphetamine nc nc nc nc nc nc nc nc nc 0.26 0.10 0.22 0.15 0.21 *
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc 1.17 1.14 1.08 1.06 1.05 1.24
Pain Relievers nc nc nc nc nc nc nc nc nc 0.95 0.98 0.77 0.82 0.76 0.59
Stimulants nc nc nc nc nc nc nc nc nc 0.89 0.83 0.84 0.62 0.90 1.01
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc 0.65 0.77 0.76 0.77 0.80 0.98
Tranquilizers nc nc nc nc nc nc nc nc nc 0.59 0.78 0.75 0.73 0.77 0.95
Sedatives nc nc nc nc nc nc nc nc nc 0.35 0.38 0.24 0.38 0.52 0.23
Benzodiazepines nc nc nc nc nc nc nc nc nc 0.57 0.75 0.75 0.72 0.77 0.85
Opioids nc nc nc nc nc nc nc nc nc 0.95 0.97 0.77 0.82 0.76 0.59
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc 0.92 0.86 0.85 0.67 0.93 1.07
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc 1.40 1.23 1.26 1.19 1.17 1.84
PAST MONTH USE                              
Alcohol 1.66 1.72 1.69 1.55 1.61 1.59 1.46 1.27 1.42 1.30 1.18 1.26 1.27 1.19 2.02
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc 1.07 0.92 0.99 0.99 0.95 1.24
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc 0.56 0.45 0.33 0.21 0.35 0.83
Cigarette Use 1.55 1.41 1.37 1.44 1.29 1.21 1.09 1.01 1.00 1.00 0.87 0.84 0.79 0.62 0.88
Daily Cigarette Use 0.86 0.79 0.65 0.66 0.55 0.64 0.50 0.32 0.53 0.55 0.22 0.30 0.25 0.16 0.16
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
NOTE: Respondents with unknown impairment data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2006-2019, and Quarters 1 and 4, 2020.
210609
Table 11.8C – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with No Major Depressive Episode in Past Year; Standard Errors of Numbers in Thousands, 2004-2020
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                                  
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 90 84 88 87 87 138
Marijuana 76 76 77 74 73 78 87 81 79 72 76 75 71 79 76 77 121
Cocaine 25 25 25 23 20 21 20 16 17 12 18 18 15 14 13 14 20
Crack 8 8 10 9 6 5 3 5 7 3 2 3 3 6 1 1 2
Heroin 9 6 7 5 9 6 7 9 8 6 5 6 4 4 3 * *
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 33 27 30 25 27 37
LSD 15 15 13 14 16 11 16 14 13 13 21 23 18 19 18 21 29
PCP 9 13 10 9 8 9 7 6 10 5 7 10 5 5 3 6 *
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 21 17 18 15 14 15
Inhalants nc nc nc nc nc nc nc nc nc nc nc 33 28 29 33 33 55
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 7 7 8 8 8 6
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 52 46 44 42 41 67
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 41 36 35 33 31 57
Stimulants nc nc nc nc nc nc nc nc nc nc nc 28 27 26 22 26 39
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 32 26 28 25 26 29
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 29 25 26 25 26 27
Sedatives nc nc nc nc nc nc nc nc nc nc nc 13 12 12 9 9 12
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 29 24 26 25 25 26
Opioids nc nc nc nc nc nc nc nc nc nc nc 42 36 35 33 31 57
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc nc nc 33 28 28 25 28 42
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 67 55 56 57 55 91
PAST MONTH USE                                  
Alcohol 87 85 84 88 80 84 81 77 83 73 74 66 69 68 65 74 124
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 52 48 50 48 48 101
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 20 17 17 16 21 30
Cigarette Use 74 68 64 64 55 62 62 56 51 45 45 41 36 35 31 29 42
Daily Cigarette Use 35 31 31 31 27 28 27 25 23 19 24 18 14 11 13 10 11
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.8D – Substance Use in Past Year and Past Month: Among People Aged 12 to 17 with No Major Depressive Episode in Past Year; Standard Errors of Percentages, 2004-2020
Substance 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
PAST YEAR USE                                  
Illicit Drugs nc nc nc nc nc nc nc nc nc nc nc 0.38 0.36 0.37 0.40 0.38 0.64
Marijuana 0.31 0.30 0.31 0.30 0.29 0.32 0.36 0.34 0.31 0.31 0.33 0.33 0.31 0.34 0.35 0.35 0.57
Cocaine 0.11 0.11 0.11 0.10 0.09 0.09 0.09 0.07 0.07 0.05 0.09 0.08 0.07 0.06 0.06 0.07 0.10
Crack 0.04 0.03 0.04 0.04 0.02 0.02 0.01 0.02 0.03 0.01 0.01 0.01 0.01 0.03 0.01 0.01 0.01
Heroin 0.04 0.03 0.03 0.02 0.04 0.03 0.03 0.04 0.04 0.03 0.03 0.03 0.02 0.02 0.01 * *
Hallucinogens nc nc nc nc nc nc nc nc nc nc nc 0.15 0.13 0.14 0.12 0.13 0.18
LSD 0.07 0.06 0.05 0.06 0.07 0.05 0.07 0.06 0.06 0.06 0.10 0.11 0.08 0.09 0.09 0.10 0.15
PCP 0.04 0.06 0.05 0.04 0.03 0.04 0.03 0.02 0.05 0.02 0.03 0.05 0.02 0.02 0.02 0.03 *
Ecstasy nc nc nc nc nc nc nc nc nc nc nc 0.10 0.08 0.08 0.07 0.07 0.07
Inhalants nc nc nc nc nc nc nc nc nc nc nc 0.15 0.13 0.14 0.16 0.16 0.27
Methamphetamine nc nc nc nc nc nc nc nc nc nc nc 0.03 0.03 0.04 0.04 0.04 0.03
Misuse of Prescription Psychotherapeutics nc nc nc nc nc nc nc nc nc nc nc 0.23 0.21 0.21 0.20 0.20 0.33
Pain Relievers nc nc nc nc nc nc nc nc nc nc nc 0.19 0.17 0.16 0.16 0.15 0.28
Stimulants nc nc nc nc nc nc nc nc nc nc nc 0.13 0.12 0.12 0.11 0.13 0.19
Tranquilizers or Sedatives nc nc nc nc nc nc nc nc nc nc nc 0.15 0.12 0.13 0.12 0.13 0.14
Tranquilizers nc nc nc nc nc nc nc nc nc nc nc 0.14 0.11 0.12 0.12 0.13 0.13
Sedatives nc nc nc nc nc nc nc nc nc nc nc 0.06 0.05 0.06 0.04 0.04 0.06
Benzodiazepines nc nc nc nc nc nc nc nc nc nc nc 0.13 0.11 0.12 0.12 0.12 0.13
Opioids nc nc nc nc nc nc nc nc nc nc nc 0.19 0.17 0.16 0.16 0.15 0.28
Central Nervous System Stimulants nc nc nc nc nc nc nc nc nc nc nc 0.15 0.13 0.13 0.12 0.14 0.21
Illicit Drugs Other Than Marijuana1 nc nc nc nc nc nc nc nc nc nc nc 0.30 0.24 0.26 0.27 0.26 0.44
PAST MONTH USE                                  
Alcohol 0.33 0.33 0.34 0.35 0.32 0.33 0.33 0.31 0.32 0.31 0.32 0.30 0.31 0.31 0.29 0.33 0.58
Binge Alcohol Use2 nc nc nc nc nc nc nc nc nc nc nc 0.24 0.22 0.23 0.22 0.22 0.48
Heavy Alcohol Use nc nc nc nc nc nc nc nc nc nc nc 0.10 0.08 0.08 0.08 0.10 0.15
Cigarette Use 0.30 0.29 0.27 0.27 0.24 0.26 0.27 0.24 0.22 0.20 0.20 0.19 0.17 0.16 0.15 0.14 0.20
Daily Cigarette Use 0.15 0.13 0.14 0.14 0.12 0.12 0.12 0.11 0.10 0.09 0.11 0.08 0.07 0.05 0.06 0.05 0.05
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
1 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs.
2 Estimates of binge alcohol use include use by those who were heavy alcohol users.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.9C – Type of Treatment Received in Past Year for Depression: Among People Aged 12 to 17 with Major Depressive Episode (MDE) in Past Year and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; Standard Errors of Numbers in Thousands, 2004-2020
MDE/Type of Treatment 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
MDE                                  
Saw or Talked to a Health Professional
OR Used Prescription Medication
39 38 37 40 35 35 35 35 37 43 50 51 51 54 59 63 137
Saw or Talked to a Health Professional
   BUT Did Not Use Prescription Medication
30 28 28 27 27 26 25 26 27 31 36 38 37 37 46 42 112
Used Prescription Medication BUT Did Not
   See or Talk to a Health Professional
11 10 9 11 10 9 12 10 9 17 14 14 11 13 12 19 16
Saw or Talked to a Health Professional
   AND Used Prescription Medication
25 24 21 24 21 20 20 21 23 23 32 30 34 37 33 41 77
MDE with Severe Impairment                                  
Saw or Talked to a Health Professional
OR Used Prescription Medication
-- -- 34 34 31 31 30 31 34 40 42 45 45 50 52 57 111
Saw or Talked to a Health Professional
   BUT Did Not Use Prescription
   Medication
-- -- 25 23 23 23 22 22 23 28 30 33 30 33 40 38 86
Used Prescription Medication BUT
   Did Not See or Talk to a Health
   Professional
-- -- 8 9 9 9 9 7 9 17 13 13 10 12 10 17 13
Saw or Talked to a Health Professional
   AND Used Prescription Medication
-- -- 20 22 20 19 18 20 22 23 27 28 32 34 31 38 69
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.
210609
Table 11.9D – Type of Treatment Received in Past Year for Depression: Among People Aged 12 to 17 with Major Depressive Episode (MDE) in Past Year and among People Aged 12 to 17 with MDE with Severe Impairment in Past Year; Standard Errors of Percentages, 2004-2020
MDE/Type of Treatment 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
MDE                                  
Saw or Talked to a Health Professional
OR Used Prescription Medication
1.35 1.40 1.54 1.51 1.45 1.51 1.48 1.45 1.35 1.35 1.42 1.37 1.29 1.26 1.36 1.34 2.46
Saw or Talked to a Health Professional
   BUT Did Not Use Prescription Medication
1.21 1.19 1.30 1.17 1.22 1.19 1.22 1.20 1.10 1.10 1.19 1.12 1.09 1.04 1.20 1.03 2.32
Used Prescription Medication BUT Did Not
   See or Talk to a Health Professional
0.47 0.45 0.47 0.52 0.48 0.47 0.63 0.50 0.40 0.65 0.50 0.47 0.36 0.41 0.36 0.50 0.38
Saw or Talked to a Health Professional
   AND Used Prescription Medication
1.03 1.02 0.98 1.10 1.00 0.99 0.95 0.97 0.97 0.86 1.07 0.94 1.02 1.01 0.89 0.98 1.71
MDE with Severe Impairment                                  
Saw or Talked to a Health Professional
OR Used Prescription Medication
-- -- 1.97 1.90 1.69 1.82 1.78 1.76 1.67 1.61 1.66 1.61 1.57 1.55 1.66 1.64 2.70
Saw or Talked to a Health Professional
   BUT Did Not Use Prescription
   Medication
-- -- 1.65 1.43 1.44 1.48 1.47 1.45 1.31 1.34 1.36 1.40 1.27 1.28 1.45 1.28 2.46
Used Prescription Medication BUT
   Did Not See or Talk to a Health
   Professional
-- -- 0.61 0.66 0.61 0.63 0.63 0.51 0.54 0.87 0.63 0.59 0.45 0.51 0.43 0.61 0.44
Saw or Talked to a Health Professional
   AND Used Prescription Medication
-- -- 1.34 1.44 1.30 1.24 1.24 1.29 1.29 1.14 1.26 1.15 1.35 1.31 1.18 1.29 2.16
* = low precision; -- = not available; da = does not apply; nc = not comparable due to methodological changes; nr = not reported due to measurement issues.
NOTE: Estimates in the 2020 column are italicized to indicate caution should be used when comparing estimates between 2020 and prior years because of methodological changes for 2020. Due to these changes, significance testing between 2020 and prior years was not performed. See the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions for details.
NOTE: Some 2006 to 2010 estimates may differ from previously published estimates due to updates (see Chapter 3 of the 2020 National Survey on Drug Use and Health: Methodological Summary and Definitions).
NOTE: Respondents with unknown past year treatment for depression data were excluded.
NOTE: Respondents with unknown past year Major Depressive Episode (MDE) data were excluded.
Definitions: Measures and terms are defined in Appendix A.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2004-2019, and Quarters 1 and 4, 2020.

Go to Top of PageGo to the Table of Contents